Company
acclinate.com
Acclinate - Clinical Trial Diversity & Health Equity
Also known as Acclinate, Inc
- Business model
- B2B
- Legal name
- Acclinate, Inc
Claim, correct or request removal
Record updated 29 September 2026
About
Acclinate fuses community trust with patented AI to deliver predictive enrollment data. Accelerate trials, meet diversity goals, reduce risk.
Funding snapshot
- Total raised
- $14.4MSEC form D sum, as of 2026-09-29Source (opens in a new tab)
- Latest round
- Round, $3.5M2026-02-11
Funding rounds
- Round, 2026
- $3.5M2026-02-11, SEC form D sold, 5 investors
- Round, 2024
- $6M2024-05-03, SEC form D sold, 6 investors
- Round, 2022
- $4.9M2022-10-03, SEC form D sold, 25 investors
Loading relationship preview